FOS and CLU

  • Number of citations of the paper that reports this interaction (PMID 20195357)
  • 18

FOS

CLU

Gene Name FBJ murine osteosarcoma viral oncogene homolog clusterin
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 108 interactors: ANP32E APP AQP1 ARFGAP1 ARL6IP4 ATF2 ATF3 ATF4 ATF7 ATP5I BATF BCL3 CABP1 CARM1 CEBPA CEBPE CEBPG CENPO CFAP57 CLU COPS4 CREB5 CREBBP CSNK2A1 CSNK2A2 CYTH4 DDIT3 EEF1D ELK1 ELK4 EPHB2 ETS1 ETS2 GAMT GATA4 GLB1 GNG11 GRHPR GTF2E2 GTF2F1 GTF2F2 HNF1A HSPA1A JUN JUNB JUND KDM2A LMNA LMO3 LUZP4 MAF MAFB MAFF MAP1B MAP3K7 MAPK1 MAPK7 MITF MTERF4 NACA NCOA1 NCOA2 NCOA3 NCOA6 NCOR2 NEFM NELFB NFATC3 NFKB1 OPTN PML POLR2E PRKAA2 PRKACA PSMC5 RB1 RELA RPS6KA1 RPS6KA2 RPS6KA4 RUNX1 RUNX2 SCHIP1 SET SIRT1 SMAD3 SMARCD1 SPI1 SRA1 STAT1 SUMO1 SUMO2 SUMO3 SUMO4 TAF1 TBP TRO TSC22D3 TSPAN2 UBE2D1 UBE2I UBE2L3 UBR1 USF1 USF2 VDR XBP1 ZNF133 44 interactors: APP BAG6 C7 C8B C9 CBY1 CD209 CLUAP1 CYP2E1 DISC1 ELN FOS GRB2 HSPD1 IL24 KATNA1 KEAP1 KLF11 KNSTRN LEP LEPR LIG4 LRP2 LRP8 LYZ MAPK9 MDM2 MMP25 PAXIP1 POLR1C PON1 PRNP RBBP8 RPL23 SYVN1 TGFBR1 TGFBR2 TNIK TSC22D4 TTR VHL VLDLR XRCC6 ZWINT
Entrez ID 2353 1191
HPRD ID 01275 01706
Ensembl ID ENSG00000170345 ENSG00000120885
Uniprot IDs B4DQ65 P01100 Q6FG41 P10909
PDB IDs 1A02 1FOS 1S9K
Enriched GO Terms of Interacting Partners?
Tagcloud ?
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
allometric  allometry  amphotericin  bolus  cmin  contributions  cpeak  disposition  hplc  humans  insignificant  inspite  interspecies  mrt  parameter  perform  pharmacokinetic  pharmacokinetics  predictions  preliminary  rabbits  rationalized  scaling  t0  triexponential  vdarea  vss  vuss 
Tagcloud (Difference) ?
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
allometric  allometry  amphotericin  bolus  cmin  contributions  cpeak  disposition  hplc  humans  insignificant  inspite  interspecies  mrt  parameter  perform  pharmacokinetic  pharmacokinetics  predictions  preliminary  rabbits  rationalized  scaling  t0  triexponential  vdarea  vss  vuss 
Tagcloud (Intersection) ?